365
Views
6
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Effects of genistein on lipopolysaccharide-induced injury of mouse alveolar epithelial cells and its mechanism

, , , , & ORCID Icon
Pages 544-551 | Received 17 Sep 2019, Accepted 19 Nov 2019, Published online: 03 Dec 2019

Figures & data

Figure 1. Effects of genistein on viability of MLE-12 cells.

(a) Low concentration of genistein (1–10 µM) did not affect cell viability, while 25 µM genistein inhibited cell viability by spectrophotometric method 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) experiment. **p < 0.001 vs. genistein (0 µM). (b) High concentration of genistein did not affect cell viability, lipopolysaccharide (LPS) inhibited cell viability, PBEF inhibitor FK866 induces increased cell viability and genistein enhanced LPS-induced low cell viability in a concentration-dependent manner by MTT experiment. **p < 0.001 vs. Control; ##p < 0.001 vs. LPS; ^^p < 0.001 vs. LPS + L-GENISTEIN; ΦΦP<0.001 vs. LPS + H-GENISTEIN.

Figure 1. Effects of genistein on viability of MLE-12 cells.(a) Low concentration of genistein (1–10 µM) did not affect cell viability, while 25 µM genistein inhibited cell viability by spectrophotometric method 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) experiment. **p < 0.001 vs. genistein (0 µM). (b) High concentration of genistein did not affect cell viability, lipopolysaccharide (LPS) inhibited cell viability, PBEF inhibitor FK866 induces increased cell viability and genistein enhanced LPS-induced low cell viability in a concentration-dependent manner by MTT experiment. **p < 0.001 vs. Control; ##p < 0.001 vs. LPS; ^^p < 0.001 vs. LPS + L-GENISTEIN; ΦΦP<0.001 vs. LPS + H-GENISTEIN.

Figure 2. Effects of genistein on inflammatory factors and apoptosis of MLE-12 cells.

(a–d) High concentration of genistein treatment alone had no significant effect on the levels of inflammatory factors. LPS increased the contents of inflammatory factors, FK866 induced decreased contents of inflammatory factors and genistein decreased LPS-induced high levels of inflammatory factors in a concentration-dependent manner by enzyme-linked immunosorbent assay (ELISA). (e) High concentration of genistein alone had no significant effect on apoptosis of MLE-12 cells. LPS increased the apoptotic rate, FK866 induced decreased cell apoptotic rate and genistein decreased the apoptotic rate of MLE-12 cells in a concentration-dependent manner by flow cytometry test. **p < 0.001 vs. Control; ##p < 0.001 vs. LPS; ^^p < 0.001 vs. LPS + L-GENISTEIN; ΦΦP<0.001 vs. LPS + H-GENISTEIN.

Figure 2. Effects of genistein on inflammatory factors and apoptosis of MLE-12 cells.(a–d) High concentration of genistein treatment alone had no significant effect on the levels of inflammatory factors. LPS increased the contents of inflammatory factors, FK866 induced decreased contents of inflammatory factors and genistein decreased LPS-induced high levels of inflammatory factors in a concentration-dependent manner by enzyme-linked immunosorbent assay (ELISA). (e) High concentration of genistein alone had no significant effect on apoptosis of MLE-12 cells. LPS increased the apoptotic rate, FK866 induced decreased cell apoptotic rate and genistein decreased the apoptotic rate of MLE-12 cells in a concentration-dependent manner by flow cytometry test. **p < 0.001 vs. Control; ##p < 0.001 vs. LPS; ^^p < 0.001 vs. LPS + L-GENISTEIN; ΦΦP<0.001 vs. LPS + H-GENISTEIN.

Figure 3. Effects of genistein on PBEF and NF-κB pathway protein.

(a) High concentration of genistein treatment alone had no significant effect on PBEF expression. LPS up-regulated the expression of PBEF, while high concentration of genistein and FK866 decreased PBEF expression by western blot (WB) analysis. (b–c) High concentration of genistein treatment alone had no significant effect on p65 expression. LPS up-regulated nuclear p65 and down-regulated cytoplasmic p65, H-GENISTEIN and FK866 down-regulated nuclear p65 and up-regulated cytoplasmic p65 western blotting analysis. **p < 0.001 vs. Control; ##p < 0.001 vs. LPS; ΦP<0.05, ΦΦP<0.001 vs. LPS + H-GENISTEIN.

Figure 3. Effects of genistein on PBEF and NF-κB pathway protein.(a) High concentration of genistein treatment alone had no significant effect on PBEF expression. LPS up-regulated the expression of PBEF, while high concentration of genistein and FK866 decreased PBEF expression by western blot (WB) analysis. (b–c) High concentration of genistein treatment alone had no significant effect on p65 expression. LPS up-regulated nuclear p65 and down-regulated cytoplasmic p65, H-GENISTEIN and FK866 down-regulated nuclear p65 and up-regulated cytoplasmic p65 western blotting analysis. **p < 0.001 vs. Control; ##p < 0.001 vs. LPS; ΦP<0.05, ΦΦP<0.001 vs. LPS + H-GENISTEIN.

Figure 4. Effects of genistein on keratinocyte-derived chemokine (KC) and MLE-12 cells apoptosis via regulating PBEF.

(a–b) WB test showed that PBEF transfection was successful. (c) Overexpression of PBEF attenuated the inhibitory effect of genistein on KC release. (d) Overexpression of PBEF attenuated the inhibitory effect of GENISTEIN on MLE-12 cell apoptosis. **p < 0.001 vs. NC.

Figure 4. Effects of genistein on keratinocyte-derived chemokine (KC) and MLE-12 cells apoptosis via regulating PBEF.(a–b) WB test showed that PBEF transfection was successful. (c) Overexpression of PBEF attenuated the inhibitory effect of genistein on KC release. (d) Overexpression of PBEF attenuated the inhibitory effect of GENISTEIN on MLE-12 cell apoptosis. **p < 0.001 vs. NC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.